fda glp-1 safety warning september 2025 2024 Ends With Lilly's Landmark Sleep Apnea Approval NCL Issues a Second Alert

Semaglutide, sold under the brand names Ozempic, Wegovy and Rybelsus, is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management, developed by Novo Nordisk in 2012

Whether you choose semaglutide or compounded semaglutide, just hop on a quick phone or video consultation with one of our experienced providers

While fat loss typically requires a calorie deficit, a moderate deficit combined with adequate protein and resistance training can allow for body recomposition, or losing fat while preserving or even gaining muscle

What should patients know

Aiding the body's ability to generate fat cell mobilisation so it can be used as energy by the body